GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) » Definitions » Scaled Net Operating Assets

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Scaled Net Operating Assets : 0.63 (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sichuan Kelun Pharmaceutical Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sichuan Kelun Pharmaceutical Co's operating assets for the quarter that ended in Sep. 2024 was ¥31,308 Mil. Sichuan Kelun Pharmaceutical Co's operating liabilities for the quarter that ended in Sep. 2024 was ¥7,372 Mil. Sichuan Kelun Pharmaceutical Co's Total Assets for the quarter that ended in Jun. 2024 was ¥38,041 Mil. Therefore, Sichuan Kelun Pharmaceutical Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.63.


Sichuan Kelun Pharmaceutical Co Scaled Net Operating Assets Historical Data

The historical data trend for Sichuan Kelun Pharmaceutical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Kelun Pharmaceutical Co Scaled Net Operating Assets Chart

Sichuan Kelun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.72 0.66 0.69 0.70

Sichuan Kelun Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.66 0.67 0.65 0.63

Competitive Comparison of Sichuan Kelun Pharmaceutical Co's Scaled Net Operating Assets

For the Drug Manufacturers - General subindustry, Sichuan Kelun Pharmaceutical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sichuan Kelun Pharmaceutical Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sichuan Kelun Pharmaceutical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Sichuan Kelun Pharmaceutical Co's Scaled Net Operating Assets falls into.


;
;

Sichuan Kelun Pharmaceutical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sichuan Kelun Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(30088.339-6299.836)/34205.984
=0.70

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=36454.901 - 6366.562
=30088.339

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=13439.308 - 2893.814 - 4245.658
=6299.836

Sichuan Kelun Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(31308.479-7372.219)/38041.07
=0.63

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=38392.364 - 7083.885
=31308.479

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=12160.921 - 1447.79 - 3340.912
=7372.219

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Kelun Pharmaceutical Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun Pharmaceutical Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Kelun Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.36 West Baihua Road, Qingyang District, Chengdu, CHN, 610071
Sichuan Kelun Pharmaceutical Co Ltd is a China-based Pharmaceutical company mainly focused on the production and sales of injection products, including products for glucose injection and sodium chloride injection. It manufactures and sells high-volume injections (infusions), small-volume injections (water needles), sterile powder injections (containing powdered and freeze-dried powder). Its products include tablets, capsules, capsules, granules, oral liquids, peritoneal dialysis fluids, raw material medicines, medical packaging materials, medical instruments, and antibiotic intermediates.
Executives
Lai De Gui Executives
Feng Hao Directors, executives
Liu Si Chuan Directors, executives
Wang Jing Yi Directors, executives
Wan Yang Yu Executives
Ge Jun You Executives
Wu Zhong Hua Executives
Wan Peng Supervisors
Tan Hong Bo Executives
Liu Ge Xin Director
Huang Xin Securities Affairs Representative
Ge Tao Executives
Pan Hui Directors, executives
Zhou Xiao Dong Executives
Zheng Chang Yan Supervisors

Sichuan Kelun Pharmaceutical Co Headlines

No Headlines